Genetic Technologies Ltd (GENE)
US37185R4065 - ADR
| 2024 (2024-6-30) | 2023 (2023-6-30) | 2022 (2022-6-30) | 2021 (2021-6-30) | 2020 (2020-6-30) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Change In Working Capital | 1.75M | 1.96M | 2.40M | 1.33M | 1.04M | |||
| OPERATING CASH FLOW | -9.68M | -9.72M | -5.66M | -6.30M | -5.71M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -32.97K | -17.55K | -96.79K | -748.71K | -38.10K | |||
| Other Investing Activity | 147.87K | -294.39K | -3.36M | 0.00 | 102.89K | |||
| INVESTING CASH FLOW | 114.90K | -311.94K | -3.46M | -748.71K | 64.79K | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 252.09K | -336.40K | -268.59K | -236.89K | -131.66K | |||
| Stock Issued/Repurchased | 2.58M | 7.17M | 0.00 | 15.90M | 21.79M | |||
| Other Financing Activity | -6.85K | -916.06K | -10.47K | -1.97M | -3.30M | |||
| FINANCING CASH FLOW | 2.82M | 5.92M | -279.06K | 13.69M | 18.36M | |||
| Exchange Rate Effect | -88.83K | 234.96K | 228.73K | 42.76K | -630.62K | |||
| CHANGE IN CASH | -6.83M | -3.88M | -9.17M | 6.69M | 12.08M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -9.68M | -9.72M | -5.66M | -6.30M | -5.71M | |||
| Capital Expenditure | -32.97K | -17.55K | -96.79K | -748.71K | -38.10K | |||
| FREE CASH FLOW | -9.71M | -9.74M | -5.76M | -7.04M | -5.75M | |||
All data in AUD